Skip to main content
Have a personal or library account? Click to login
Development of bioflavonoid containing chemotherapeutic delivery systems for UV-damaged skin and kangri cancer Cover

Development of bioflavonoid containing chemotherapeutic delivery systems for UV-damaged skin and kangri cancer

Open Access
|Oct 2022

Figures & Tables

Table 1

Ingredients list for preparation of FU microemulsion.

IngredientProperty
5-FUDrug
Tween 20Surfactant
Isopropyl alcoholCosurfactant
Isopropyl myristateOil
DMSOPenetration enhancer
RutinAntioxidant
Table 2

Solubility of R-5FU in different oils, surfactants and co-surfactants.

OilSolubility(mg/ml)
Isopropyl myristate165.28
Oleic acid183.12
Castor oil44.26
Olive oil32.61
SurfactantSolubility (mg/ml)
Tween 80105.28
Tween 2093.12
Span 8058.27
Span 2031.62
CosurfactantSolubility (mg/ml)
Isopropyl alcohol107.28
Ethanol43.12
N-butanol58.27
Polyethylene glycol69.62
Propylene glycol79.62
Table 3

Viscosity of prepared microemulsion batches.

Batch no.Viscosity
RME114.68
RME216.52
RME317.25
Figure 1

Phase diagram of 1:1 weight ratio of microemulsion.

Figure 2

Phase diagram of 2:1 weight ratio of microemulsion.

Figure 3

Phase diagram of 3:1 weight ratio of microemulsion.

Figure 4

Transmission electron microscopic surface area of prepared microemulsion batches.

Figure 5

Viscosity of microemulsion batches.

Table 4

pH of prepared microemulsion batches.

Batch no.pH
RME15.24
RME25.93
RME35.67
Figure 6

Graph of pH values of microemulsion batches.

Figure 7

Globules size range of prepared microemulsion batches.

Table 5

Values of drug permeation of prepared microemulsion batches.

Time5-FURME1RME2RME3
AbsorptionAbsorptionAbsorptionAbsorption
0 min0.1280.1280.1350.138
1 min0.1300.1450.1520.156
2 min0.1610.1650.1740.178
3 min0.1820.1930.2030.208
4 min0.2170.2320.2440.251
5 min0.2750.2910.3050.312
10 min0.3580.3860.4060.416
30 min0.5100.5810.610.625
60 min1.0121.1611.221.25
3 hours1.0121.1611.221.25
Figure 8

Comparative skin retention profile for the all the formulation 5-FU

Figure 9

Percentage (%) mean cumulative 5-FU microemulsions penetration in skin.

Table 6

Scoring for irritation testing (HET-CAM assay).

0.5 min2 min5 min
RME1Lysis------0Non-irritant
Hemorrhage------
Coagulation------
RME2Lysis-----0Non-irritant
Hemorrhage------
Coagulation------
RME3Lysis------0Non-irritant
Hemorrhage------
Coagulation------
Control (0.9%NaCl)Lysis------0non-irritant
Hemorrhage------
Coagulation------
Irritant (0.1 N NaOH)Lysis--7--23Severe-irritant
Hemorrhage7----
Coagulation9----
Table 7

Effects of RME1, RME2, RME3, control and irritant on chorioallantoic membrane with different time interval.

Groups: -
RME1 graphic/j_fco-2021-0012_ingr_001.png graphic/j_fco-2021-0012_ingr_002.png graphic/j_fco-2021-0012_ingr_003.png
RME2 graphic/j_fco-2021-0012_ingr_004.png graphic/j_fco-2021-0012_ingr_005.png graphic/j_fco-2021-0012_ingr_006.png
RME3 graphic/j_fco-2021-0012_ingr_007.png graphic/j_fco-2021-0012_ingr_008.png graphic/j_fco-2021-0012_ingr_009.png
Control graphic/j_fco-2021-0012_ingr_010.png graphic/j_fco-2021-0012_ingr_011.png graphic/j_fco-2021-0012_ingr_012.png
Irritant graphic/j_fco-2021-0012_ingr_013.png graphic/j_fco-2021-0012_ingr_014.png graphic/j_fco-2021-0012_ingr_015.png
Figure 10

Acute skin irritation test of prepared microemulsion batches (a) RME 1, (b) RME 2, (c) RME 3 and control (d).

Table 8

Mean erythemal score evaluated for different formulation.

Erythemal Score (n-6)
Days25710141821
Control0000000
RME10000001
RME20000011
RME30000011
Formalin (0.8%)0011233
DOI: https://doi.org/10.2478/fco-2021-0012 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 86 - 98
Submitted on: Nov 6, 2021
Accepted on: Jan 26, 2022
Published on: Oct 23, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services

© 2022 Harish Sharma, Gyanesh Kumar Sahu, Chanchal Deep Kaur, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.